Home » Posts tagged with » Ian Henshaw
FDA accepts BLA for Lucentis referencing ophthalmology biosimilar SB11
Samsung Bioepis and Biogen said that the US Food and Drug Administration (FDA) has accepted for review the biologics license application for SB11, a proposed ophthalmology biosimilar referencing Genentech’s Lucentis (ranibizumab). Ranibizumab is an anti vascular endothelial growth factor (VEGF) therapy for retinal vascular disorders, which are a major cause of blindness in the US. […]
Business News Today
- Önusberget wind farm : GE Renewable Energy bags contract for 137 turbines
- El Campo project : Ely Gold Royalties acquires heavy rare earth project in California
- NER-II transmission project : IndiGrid to acquire NER-II from Sterlite Power for $630m
- Wipro to acquire management and technology consultancy Capco for $1.4bn
- Dabur India launches Dabur Vatika Select shampoo range
- KKR to acquire majority stake in Integrated Specialty Coverages
- Amgen to acquire Five Prime Therapeutics for gastric cancer candidate bemarituzumab
- Adani Ports to acquire stake in Gangavaram Port for $270m
- Infosys to create 500 new jobs in Calgary amid Canadian expansion
- Boston Scientific to acquire Lumenis surgical business for $1bn